Cargando…
Lessons Learned From Limited Overlap of 15 In Vitro COVID-19 Drug Repurposing Screens
Drug repurposing can quickly and cost-effectively identify medical countermeasures against pathogens with pandemic potential and could be used as a down-selection method for selecting US Food and Drug Administration-approved drugs to test in clinical trials. We compared results from 15 high-throughp...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357111/ https://www.ncbi.nlm.nih.gov/pubmed/37196212 http://dx.doi.org/10.1089/hs.2022.0132 |